The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
Am J Respir Crit Care Med
.
2022 Apr 15;205(8):867-869.
doi: 10.1164/rccm.202201-0018ED.
Authors
Giacomo Sgalla
1
,
Marlies S Wijsenbeek
2
,
Luca Richeldi
1
Affiliations
1
Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica del Sacro Cuore Rome, Italy.
2
Centre for Interstitial Lung Diseases and Sarcoidosis Erasmus University Medical Centre Rotterdam Rotterdam, the Netherlands.
PMID:
35134312
PMCID:
PMC9838618
DOI:
10.1164/rccm.202201-0018ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Idiopathic Pulmonary Fibrosis* / drug therapy
Pyridones
Substances
Pyridones